Heparin using in haemodialysis

Zbigniew Zdrojewski

ISSN: 000-1323

Problemy Lekarskie/Medical Problems

Current issue Archive About the journal Contact Instructions for authors

3/2006

Send email

Copy url:

abstract:

Heparin using in haemodialysis

Zbigniew Zdrojewski

Problemy Lekarskie 2006; 45, 3: 132–135

Online publish date: 2006/09/26

View full text Get citation

To prevent clotting in the extracorporeal circuit during haemodialysis, anticoagulant treatment is mandatory. In patients without eleveted bleeding risk low-dose unfractionated heparin (UFH) or low molecular weight heparins (LMWHs) can be used. LMWHs is prefered because of proven safety, equal to UFH efficacy, easy handling and other benefits. In ptients with increased bleeding risks, systemic anticoagulation should be avoided. If it is possible, UFH is indicated with whole blood clotting time control. When side effects of heparin therapy during routine haemodialysis occur, the use of UFH has to be avoided or stoped all heparins when heparin-iduced thrombocytopenia type II was suspected

keywords:

Heparin using in haemodialysis

Zbigniew Zdrojewski

haemodialysis, unfractionated heparin, low-molecular weight heparin, side effects